Early Phase Oncology Site Network: Benefits Of A Personal Touch

By Adam Coleman

Network models at large CROs often prioritize scale: high volume, broad reach, and massive data flow. Catalyst Oncology’s early-phase site network takes a fundamentally different approach. Instead of optimizing for size, we optimize for depth: strong relationships, streamlined communication, and meaningful site engagement. Our model is intentionally designed to reduce site burden, elevate site and sponsor collaboration, and ensure that studies are executed by teams who understand the urgency and complexity of early-phase oncology research.

Grounded in Catalyst’s core values — listening, learning, flexibility, collaboration, and commitment — our site network operates on true partnership rather than transactional interactions. We take the time to understand the unique needs of both sites and sponsors, then thoughtfully pair them to ensure fit, feasibility, and flawless execution. Continuous communication keeps trials on track, while our advocacy for sites helps eliminate friction points that can delay enrollment or compromise data quality.

By aligning our values with the goals of our sites and sponsors, we create a development environment built on trust and scientific integrity. The result is a fit-for-purpose network that supports better study design, smoother trial delivery, and ultimately, a more direct path to getting life-changing therapies to the patients who need them most.